The Convergence of Stem Cell Technologies and Phenotypic Drug Discovery

Friese, Alexandra; Ursu, Andrei; Hochheimer, Andreas; Schöler, Hans R.; Waldmann, Herbert; Bruder, Jan M.

doi:10.1016/j.chembiol.2019.05.007

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

The Convergence of Stem Cell Technologies and Phenotypic Drug Discovery

MPS-Authors

/persons/resource/persons123083

Friese, Alexandra
Abt. IV: Chemische Biologie, Max Planck Institute of Molecular Physiology, Max Planck Society;

/persons/resource/persons179821

Ursu, Andrei
Abt. IV: Chemische Biologie, Max Planck Institute of Molecular Physiology, Max Planck Society;

/persons/resource/persons98735

Waldmann, Herbert
Abt. IV: Chemische Biologie, Max Planck Institute of Molecular Physiology, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

Friese, Alexandra Cell Chemical Biology.pdf
(Any fulltext), 3MB

Supplementary Material (public)

There is no public supplementary material available

Citation

Friese, A., Ursu, A., Hochheimer, A., Schöler, H. R., Waldmann, H., & Bruder, J. M. (2019). The Convergence of Stem Cell Technologies and Phenotypic Drug Discovery. Cell Chemical Biology, 26(8), 1050-1066. doi:10.1016/j.chembiol.2019.05.007.

Cite as: https://hdl.handle.net/21.11116/0000-0003-DCD8-2

Abstract

There is no abstract available